Nicox completes the acquisition of Eupharmed

December 5, 2013

Nicox S.A. (NYSE Euronext Paris: COX) today announced the completion of the acquisition of Eupharmed, a privately-held Italian ophthalmic company. This acquisition is part of Nicox’s strategy to establish sales infrastructure in the five major European markets and in the United States as it provides an established sales and marketing platform in Italy together with a broad portfolio of marketed eye care products.

For more information, please refer to:

← Back to blog page